NCT03452930 Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma Status COMPLETED Phase PHASE1
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Status RECRUITING Phase N/A
NCT03452579 Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03451799 Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma Status COMPLETED Phase PHASE1
NCT03439332 Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma Status COMPLETED Phase N/A
NCT03434262 SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors Status COMPLETED Phase PHASE1
NCT03426891 Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1
NCT03422094 Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma Status TERMINATED Phase PHASE1
NCT03405792 Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03403803 Prognosis and Therapeutic Biomarkers for Glioblastoma Patients Status TERMINATED Phase N/A
NCT03395587 Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03393000 Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects Status TERMINATED Phase PHASE3
NCT03392545 Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1) Status UNKNOWN Phase PHASE1
NCT03389230 Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03388372 Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma Status COMPLETED Phase PHASE2
NCT03383978 Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma Status RECRUITING Phase PHASE1
NCT03363659 Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme Status TERMINATED Phase PHASE2
NCT03355794 A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) Status COMPLETED Phase PHASE1